Stonewall Treatment Evaluation Project

Phase 1

Completed

• Conditions: HIV Infections; Substance Abuse
• Interventions: Behavioral: Stonewall Project

• Registration Number: NCT01129401
• Lead Sponsor: University of California, San Francisco

Brief Summary

This treatment outcome evaluation of the Stonewall Project will recruit 150 participants to complete a face-to-face assessment visit at baseline, 3-month follow-up, and 6-month follow-up to examine treatment outcome with respect to HIV risk and substance use.

Detailed Description

Stonewall Project clients who have initiated treatment within the past 60 days will be eligible for the outcome evaluation. 20% of clients are likely to be on parole or probation; these clients will be eligible to participate in the study.

Outcome measures that will be examined as part of the treatment outcome evaluation include: 1) self-reported substance use; 2) urine toxicology screening; and 3) sex risk taking.

Study Timeline

• Study Start: 2010-03
• Study First Submitted: 2010-05-06
• Study First Submitted QC: 2010-05-21
• Study First Posted: 2010-05-24
• Primary Completion: 2012-12
• Study Completion: 2014-05
• Status Verified: 2014-10
• Last Update Submitted: 2014-10-23
• Last Update Posted: 2014-10-27

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Male
• Target Recruitment: 150

Inclusion Criteria

• Participants in the outcome evaluation must have initiated services at the Stonewall Project within the past 60 days.

Read More

Exclusion Criteria

• Inability to provide informed consent as judged by the Co-PI's and study team.

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Stonewall Project Participants	Stonewall Project	-

Primary Outcome Measures

Name	Time	Method
stimulant use (measured via self-report and urine toxicology screening)	3 and 6 month follow-ups	Participants will complete a self-report measure that assesses substance use during the past month. We will examine the total number of days that stimulants (cocaine, crack, or methamphetamine) were used during the past month. We will also conduct urine toxicology screening to determine whether participants test positive for cocaine or methamphetamine metabolites at each study visit. This is an objective measure of recent stimulant use (i.e., during the past 72 hours).

Secondary Outcome Measures

Name	Time	Method
sexual risk taking	3 and 6 month follow-ups	Sexual risk taking will be assessed using a measure that allows our team to examine risk as a function of HIV status, partner type (i.e., insertive or receptive), and whether the participant was under the influence of methamphetamine. Sex risk for HIV-negative men will be defined as any unprotected anal intercourse, irrespective of the HIV serostatus of sex partners. Sex risk for HIV-positive men will be defined as unprotected anal intercourse with HIV-negative or unknown serostatus partners.

Trial Locations

Locations (2)

University of California, San Francisco; 🇺🇸 San Francisco, California, United States

San Francisco AIDS Foundation; 🇺🇸 San Francisco, California, United States